Format

Send to

Choose Destination
Sci Rep. 2017 Sep 18;7(1):11807. doi: 10.1038/s41598-017-12048-5.

Kinase inhibitor screening using artificial neural networks and engineered cardiac biowires.

Author information

1
Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
2
Instititute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
3
Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada. m.radisic@utoronto.ca.
4
Instititute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada. m.radisic@utoronto.ca.
5
Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada. m.radisic@utoronto.ca.

Abstract

Kinase inhibitors are often used as cancer targeting agents for their ability to prevent the activation of cell growth and proliferation signals. Cardiotoxic effects have been identified for some marketed kinase inhibitors that were not detected during clinical trials. We hypothesize that more predictive cardiac functional assessments of kinase inhibitors on human myocardium can be established by combining a high-throughput two-dimensional (2D) screening assay and a high-content three-dimensional (3D) engineered cardiac tissue (BiowireTM) based assay, and using human induced pluripotent stem cell-derived CMs (hiPSC-CMs). A subset (80) of compounds from the GlaxoSmithKline published kinase inhibitor set were tested on hiPSC-CM monolayers and significant effects on cell viability, calcium transients, and contraction frequency were observed. Artificial neural network modelling was then used to analyze the experimental results in an efficient and unbiased manner to select for kinase inhibitors with minimal effects on cell viability and function. Inhibitors of specific interest based on the modeling were evaluated in the 3D Biowire tissues. The three-dimensional Biowire platform eliminated oversensitivity in detecting both Ca2+ transient amplitude enhancements as well as the acute detrimental effects on cell viability due to the kinase inhibitor application as compared to the monolayer testing.

PMID:
28924210
PMCID:
PMC5603510
DOI:
10.1038/s41598-017-12048-5
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center